scholarly article | Q13442814 |
P50 | author | Gail D'Onofrio | Q43201466 |
E Jennifer Edelman | Q86191217 | ||
Kathryn Hawk | Q87052099 | ||
P2093 | author name string | David A Fiellin | |
Paul VanVeldhuisen | |||
Patrick G O'Connor | |||
Marek C Chawarski | |||
Michael V Pantalon | |||
Sean M Murphy | |||
Patricia H Owens | |||
Neal Oden | |||
Kristen Huntley | |||
Shara H Martel | |||
P2860 | cites work | Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence | Q24200539 |
Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes | Q24236780 | ||
The PHQ-9: validity of a brief depression severity measure | Q24550620 | ||
Organizational readiness to change assessment (ORCA): development of an instrument based on the Promoting Action on Research in Health Services (PARIHS) framework | Q30489082 | ||
Monitoring and managing metabolic effects of antipsychotics: a cluster randomized trial of an intervention combining evidence-based quality improvement and external facilitation | Q30558767 | ||
A signed-rank test for clustered data | Q31134815 | ||
The relationship between baseline Organizational Readiness to Change Assessment subscale scores and implementation of hepatitis prevention services in substance use disorders treatment clinics: a case study | Q33986417 | ||
EQ-5D: a measure of health status from the EuroQol Group | Q34086093 | ||
Outcomes of a partnered facilitation strategy to implement primary care-mental health | Q34550876 | ||
A Guide for applying a revised version of the PARIHS framework for implementation | Q35248465 | ||
Systematic review and meta-analysis of practice facilitation within primary care settings | Q35684163 | ||
Emergency department-initiated buprenorphine/naloxone treatment for opioid dependence: a randomized clinical trial | Q35924202 | ||
Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact | Q37063730 | ||
Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. | Q37203136 | ||
Cost-effectiveness of emergency department-initiated treatment for opioid dependence | Q38620855 | ||
Economic Evaluations of Opioid Use Disorder Interventions | Q38784603 | ||
Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold | Q39268069 | ||
Moderate drinking in the first year after treatment as a predictor of three-year outcomes | Q40221506 | ||
The Opioid Crisis From Research to Practice | Q44343777 | ||
A structured instrument for estimating the economic cost of drug abuse treatment. The Drug Abuse Treatment Cost Analysis Program (DATCAP). | Q50173522 | ||
Vital Signs: Trends in Emergency Department Visits for Suspected Opioid Overdoses - United States, July 2016-September 2017. | Q55262586 | ||
Medication for Opioid Use Disorder After Nonfatal Opioid Overdose and Association With Mortality: A Cohort Study | Q64124139 | ||
A three-sample test of a masked alcohol screening questionnaire | Q67918879 | ||
Informed consent, deception, and the use of disguised alcohol questionnaires | Q69689248 | ||
Measuring physician readiness to change cancer screening: preliminary results | Q72232707 | ||
What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule? | Q80944346 | ||
Helping to End Addiction Over the Long-term: The Research Plan for the NIH HEAL Initiative | Q89083820 | ||
Prevention and Treatment of Opioid Misuse and Addiction: A Review | Q90273498 | ||
Emergency Departments - A 24/7/365 Option for Combating the Opioid Crisis | Q90758454 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | opioid use disorder | Q1639178 |
substance use disorder | Q7632070 | ||
P304 | page(s) | 48 | |
P577 | publication date | 2019-05-07 | |
P1433 | published in | Implementation Science | Q6007191 |
P1476 | title | Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (Project ED HEALTH) | |
P478 | volume | 14 |